NLC and Medtech Europe publish reflection paper on how to improve the innovative landscape of Europe in health tech
MedTech Europe in collaboration with NLC published a reflection paper outlining how Europe can provide a more attractive landscape for Innovation in health tech….
Unleash the potential of healthtech innovation. Together.
Ever since the Covid-19 crisis started, NLC has adopted the strategy “prepare for the worst, prepare for the best”. Now, six months later, we…
4 NLC Ventures shortlisted for 2020 Academic Startup Competition
Out of a total of 20 ventures that have been shortlisted for the 2020 Academic Startup Competition, no less than 4 are ventures from…
NLC formally founded and registered the new NLC Stepping Stone Fund
NLC – The European Healthtech Venture Builder formally founded and registered the new NLC Stepping Stone Fund. This means that the ‘marketing phase’ of…
How healthtech innovations arise during the COVID-19 crisis
At the start of the COVID-19 outbreak in Europe, NLC developed a website for people to share COVID-19 related ideas and innovations. With over…
NLC and MD squared conclude Framework Agreement for Venture Support
Amsterdam/Eindhoven NLC – the European HealthTech Venture Builder, has concluded a Framework Agreement with the Eindhoven based MD squared, a Medical Consultancy for Medical…
Do’s and don’ts when filing a patent
One of the most important, yet also most daunting and complicated tasks in the process of bringing an invention to the market, is securing…
NLC obtains the B Corp certificate: business as a force for good
NLC is extremely proud to announce that as of March 2020, it became a Certified B Corporation. That means that the non-profit B Lab…
Corona pandemic – the call for healthtech entrepreneurship
There are many fantastic examples in history of devastating crises that have led to a great wave of innovation. Perhaps the most famous example…